250 likes | 431 Views
Memory and Psychomotor Effects of Oxcarbazepine in healthy human volunteers. Yana M. Van Arsdale, MD, PhD. Europian Journal of Clinical Pharmacology. Springer-Verlag 1993 Institute of Psychiatry, London, UK Preliminary finding was presented at the 19 th International Epilepsy Congress, 1991
E N D
Memory and Psychomotor Effects of Oxcarbazepine in healthy human volunteers Yana M. Van Arsdale, MD, PhD
Europian Journal of Clinical Pharmacology • Springer-Verlag 1993 • Institute of Psychiatry, London, UK • Preliminary finding was presented at the 19th International Epilepsy Congress, 1991 • Supported by a grant from Ciba-Geigy
12 healthy individuals 5m, 7f, aged 21-39 Normal range height to weight ratio Recruited via advertisements within the Institute Paid for participation Screened: BMP, CBC, LFT, UA, ECG Subjects (inclusion criteria)
Subjects • No OCP (females) • Informed consent • Ethical approval • Monitoring for Hyponatremia (suggested that hyponatremia is more prononced with OXCZ)
Design • Double-blind • Balanced • Crossover • Comparison with placebo • Comparison between two doses of OXCZ • Progressive OXCZ administration over 15 days
Procedure • Training session to practice all the tests • Tests were carried out on Days 1, 8 and 15 of EACH treatment period • Blood sample was taken on days 8 and 15 to measure plasma drug concentration & plasma Sodium levels
Test Battery • Mental Rotation: Shepherd & Metzler (1971) – visuo-spatial working memory • Logic Task: Baddeley (1968) – executive component of working memory • Digit Span: Weschler (1955) • Word Recall – episodic memory • Pursuit Rotor – procedural learning
Test Battery • News recall • Word Fluency • Finger Tapping • Digit Cancellation • Symbol Coping • EEG
Test Battery • Critical Flicker Fusion Threshold (CFFT) • Subjective Ratings scale. Factors: 1. Alertness 2. Contentedness 3. Calmness • Subjective Ratings scale:Bodily Symptoms • Statistical Analyses
Memory assessments:Baddley Logic test • No significant drug effect
Memory assessment:Digit Span • Slight but Significant differences over: - testing days - times between high and low doses • Patterns of changes over time was inconsistent
Memory Asssessments: Word Recall Pursuit Rotor News Recall Word Fluency Unaffected by treatment
Psychomotor Assessments:Tapping Speed • Unaffected by treatment
Psychomotor Assessments: Symbol Coping test • Marginal difference between placebo & active drug
Psychomotor Assessments:Cancellation Time • Not significant
Electroencephalogram • No significant differences
Critical Flicker Fusion Threshold • No significant effects
Mood Rating:“Alertness” • Significant interactions between: - day of treatment and drug group - day of treatment and dose of OXCZ • Effect larger for the highest dose & more pronounced on day 8
Mood Ratings:“Contentedness” • Not affected by treatment
Mood Ratings:“Calmness” • Marginal difference between: - dose levels • Revealed a main effect of drug
Sodium Levels • WNL for all subjects on all treatments
Discussion:Summary • Results are encouraging • OXCZ has a stimulant rather than cognitive enhancement effect • Objective tests: OXCZ improves performance on a Focused Attention tasks • Objective tests: OXCZ increases manual writing speed
Discussion:Summary • Subjective rating: OXCZ increases feelings of - alertness - clearheadedness - quickwittedness • No effect on Long-Term Memory processes
Limitations • Small Sample size (12) • Time consuming tests • No follow up • No comparison with patients groups • No psychiatric evaluations of individuals involved • Limited range of assessments of - attentional processes - psychomotor functions